Four genes are recurrently mutated in 80% of cases of AITL: RHOA (50–70% of cases), TET2 (47–83%), IDH2 (20–45%) and DNMT3A (20–30%) [11,12,13,14,15,16]. This evidence concerns the gene IDH2 and angioimmunoblastic T-cell lymphoma.